Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1456109 | 1.00 | L3MBTL1 (0.59) | L3MBTL1TSHRPOLBLMNAHTT | |
| SCHEMBL13713490 | 0.92 | TSHR (0.54) | L3MBTL1TSHRPOLBLMNAHTT | |
| SCHEMBL13964395 | 0.88 | TSHR (0.50) | L3MBTL1TSHRPOLBLMNAHTT | |
| SCHEMBL10538501 | 0.88 | L3MBTL1 (0.48) | L3MBTL1TSHRPOLBLMNAHTT | |
| SCHEMBL17547266 | 0.87 | TSHR (0.72) | L3MBTL1TSHRPOLBLMNAALDH1A1 | |
| SCHEMBL23125676 | 0.86 | — | — | |
| SCHEMBL13612749 | 0.86 | TSHR (0.60) | L3MBTL1TSHRPOLBLMNAHTT | |
| SCHEMBL16272842 | 0.84 | ALDH1A1 (0.50) | L3MBTL1TSHRPOLBLMNAHTT | |
| SCHEMBL2416436 | 0.83 | HTT (0.53) | L3MBTL1TSHRPOLBLMNAHTT | |
| SCHEMBL84372 | 0.82 | TSHR (0.62) | L3MBTL1TSHRPOLBLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025064521-A1 | ULTRAFILTRATION / DIAFILTRATION PURIFICATION METHODS | PROFOUNDBIO US CO. (US) | 2025-03-27 | — | — | WO | claimed |
| EP-2445722-B2 | PRINTING METHOD | SERICOL LTD (GB) | 2024-09-04 | — | — | EP | claimed |
| EP-3512852-B1 | TRAF 6 INHIBITORS | HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) | 2024-06-26 | — | — | EP | claimed |
| CN-116283631-B | Tetrafunctional rosin UV resin, preparation method thereof and rosin-based resin photo-cured material prepared from tetrafunctional rosin UV resin | 华侨大学 | 2024-06-04 | — | — | CN | claimed |
| CN-115820110-B | High-stability water-based polyethersulfone dispersion liquid and preparation method thereof | 开封夸克新材料有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-110498776-B | Synthesis method for preparing acryloylmorpholine by using acrylamide as raw material | 浙江鑫甬生物化工股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-116283631-A | Tetrafunctional rosin UV resin, preparation method thereof and rosin-based resin photo-cured material prepared from tetrafunctional rosin UV resin | 华侨大学 | 2023-06-23 | — | — | CN | claimed |
| EP-3941906-B1 | QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER | LEAD DISCOVERY CENTER GMBH (DE) | 2023-05-03 | — | — | EP | claimed |
| CN-115820110-A | High-stability water-based polyether sulfone dispersion liquid and preparation method thereof | 开封夸克新材料有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-115784474-A | High-temperature-resistant high-pressure-resistant phosphorus-free sodium-free or low-sodium scale and corrosion inhibitor for boiler and preparation method and application thereof | 上海聚焓能源科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-20100048651-A1 | PRODRUGS OF METHYL HYDROGEN FUMARATE, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. (US) | 2010-02-25 | — | — | US | claimed |
| EP-2066647-A1 | BENZOXAZOLES AND OXAZOLOPYRIDINES BEING USEFUL AS JANUS KINASES INHIBITORS | Novartis AG (CH) | 2009-06-10 | — | — | EP | claimed |
| WO-2008031594-A1 | BENZOXAZOLES AND OXAZOLOPYRIDINES BEING USEFUL AS JANUS KINASES INHIBITORS | NOVARTIS AG (CH) | 2008-03-20 | — | — | WO | claimed |
| US-7338747-B2 | Photoresist composition and method pattern forming using the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2008-03-04 | — | — | US | claimed |
| US-20040142272-A1 | Photoresist composition and method pattern forming using the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2004-07-22 | — | — | US | claimed |
| EP-0786483-B1 | Process for an activated anionic lactam polymerisation | INVENTA AG (CH) | 2000-04-19 | — | — | EP | claimed |
| EP-0786483-A2 | Process for an activated anionic lactam polymerisation | EMS-INVENTA AG (CH) | 1997-07-30 | — | — | EP | claimed |
| US-5312459-A | Nitrogen additives to fuel | SPRUGEL FRIEDRICH A | 1994-05-17 | — | — | US | claimed |
| EP-0410202-B1 | ADDITIVE FOR LIQUIFIEDGAS-FUEL | Sprügel, Friedrich (DE) | 1992-09-30 | — | — | EP | claimed |
| EP-0410202-A1 | Additive for liquifiedgas-fuel | Sprügel, Friedrich (DE) | 1991-01-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048651-A1 | PRODRUGS OF METHYL HYDROGEN FUMARATE, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | FH, MGMT, BHMT2 | L3MBTL1 2968/4885TSHR 3968/4885POLB 1143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.